Northern Trust’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.6M Buy
1,079,723
+394,965
+58% +$585K ﹤0.01% 3119
2025
Q1
$1.75M Sell
684,758
-46,984
-6% -$120K ﹤0.01% 2988
2024
Q4
$1.38M Buy
731,742
+679,451
+1,299% +$1.28M ﹤0.01% 3234
2024
Q3
$53.3K Sell
52,291
-370,922
-88% -$378K ﹤0.01% 4191
2024
Q2
$495K Sell
423,213
-34,932
-8% -$40.9K ﹤0.01% 3514
2024
Q1
$577K Sell
458,145
-36,092
-7% -$45.5K ﹤0.01% 3518
2023
Q4
$880K Buy
494,237
+87,766
+22% +$156K ﹤0.01% 3354
2023
Q3
$675K Buy
406,471
+43,558
+12% +$72.3K ﹤0.01% 3430
2023
Q2
$726K Buy
+362,913
New +$726K ﹤0.01% 3448
2019
Q4
Sell
-3,081
Closed -$6K 4286
2019
Q3
$6K Hold
3,081
﹤0.01% 4212
2019
Q2
$15K Hold
3,081
﹤0.01% 4189
2019
Q1
$14K Hold
3,081
﹤0.01% 4151
2018
Q4
$10K Sell
3,081
-120
-4% -$389 ﹤0.01% 4200
2018
Q3
$23K Hold
3,201
﹤0.01% 4215
2018
Q2
$14K Sell
3,201
-23
-0.7% -$101 ﹤0.01% 4238
2018
Q1
$17K Hold
3,224
﹤0.01% 4178
2017
Q4
$22K Buy
3,224
+246
+8% +$1.68K ﹤0.01% 4151
2017
Q3
$17K Hold
2,978
﹤0.01% 4169
2017
Q2
$25K Hold
2,978
﹤0.01% 4164
2017
Q1
$40K Sell
2,978
-192
-6% -$2.58K ﹤0.01% 4075
2016
Q4
$14K Buy
3,170
+60
+2% +$265 ﹤0.01% 4120
2016
Q3
$18K Hold
3,110
﹤0.01% 4112
2016
Q2
$20K Hold
3,110
﹤0.01% 4119
2016
Q1
$26K Hold
3,110
﹤0.01% 4107
2015
Q4
$31K Hold
3,110
﹤0.01% 4122
2015
Q3
$36K Hold
3,110
﹤0.01% 4129
2015
Q2
$60K Buy
3,110
+15
+0.5% +$289 ﹤0.01% 4043
2015
Q1
$55K Sell
3,095
-543
-15% -$9.65K ﹤0.01% 4138
2014
Q4
$66K Buy
3,638
+36
+1% +$653 ﹤0.01% 4057
2014
Q3
$87K Buy
3,602
+56
+2% +$1.35K ﹤0.01% 4046
2014
Q2
$130K Hold
3,546
﹤0.01% 3962
2014
Q1
$162K Buy
3,546
+230
+7% +$10.5K ﹤0.01% 3839
2013
Q4
$129K Sell
3,316
-1,235
-27% -$48K ﹤0.01% 3819
2013
Q3
$206K Sell
4,551
-3,618
-44% -$164K ﹤0.01% 3656
2013
Q2
$401K Buy
+8,169
New +$401K ﹤0.01% 3496